Literature DB >> 23138731

Drug-resistant virus has reduced ability to induce immune activation.

Rui Wang, Ronald J Bosch, Constance A Benson, Michael M Lederman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23138731      PMCID： PMC3499025          DOI： 10.1097/QAI.0b013e31827171d7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  15 in total

Review 1.  International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance.

Authors:  S G Deeks
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

2.  Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study.

Authors:  Jody Lawrence; Katherine Huppler Hullsiek; Lisa M Thackeray; Donald I Abrams; Lawrence R Crane; Douglas L Mayers; Michael C Jones; Jennifer M Saldanha; Barry S Schmetter; John D Baxter
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

3.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

4.  A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.

Authors:  Constance A Benson; Florin Vaida; Diane V Havlir; Gerald F Downey; Michael M Lederman; Roy M Gulick; Marshall J Glesby; Michael Wantman; Christian J Bixby; Alex R Rinehart; Sally Snyder; Rui Wang; Sheran Patel; John W Mellors
Journal:  J Infect Dis       Date:  2006-09-22       Impact factor: 5.226

5.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

6.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

7.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164).

Authors:  Sharon L Walmsley; Anona Thorne; Mona R Loutfy; Natasha LaPierre; John MacLeod; Richard Harrigan; Benoit Trottier; Brian Conway; Joy R Hay; Joel Singer; Don Zarowny
Journal:  J Acquir Immune Defic Syndr       Date:  2007-08-01       Impact factor: 3.731

9.  The independent effect of drug resistance on T cell activation in HIV infection.

Authors:  Peter W Hunt; Steven G Deeks; David R Bangsberg; Andrew Moss; Elizabeth Sinclair; Teri Liegler; Michael Bates; Gabriel Tsao; Harry Lampiris; Rebecca Hoh; Jeffrey N Martin
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069
View more
  1 in total

1.  Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.

Authors:  Emily C Liang; Lindsay Sceats; Nicholas L Bayless; Dara M Strauss-Albee; Jessica Kubo; Philip M Grant; David Furman; Manisha Desai; David A Katzenstein; Mark M Davis; Andrew R Zolopa; Catherine A Blish
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.